Tuesday, March 26, 2024 2:29:56 PM
How does RSHN benefit? What are the terms of the agreement? When is the possible date of FINRA approval for corporate actions to resume? All RC discussions aside,having a license agreement with a private company still in the stages of pilot programs, seeking capital, while the fundamentals and financials of RSHN are in shambles doesnt hold much weight. The very first thought of the company to "rapid shareholder value" was to more than double the AS. So many factors to figure out here and alot of moving parts and mouths to feed. Need numbers. Need profit margins. Need share disbursement terms.Need agreement terms period. Alot of unanswered questions still.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM